ARCHIVES

Alimta Reduces Risk Of Progression In Patients Aged 70 Years or Older

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

Phase III Ramucirumab Trial Fails Primary Endpoint of PFS

October 25, 2013

Lung, Head & Neck Treatment Advances Reported At ASCO Annual Meeting

May 27, 1977

Bush Budget Proposal a $511 Million Cut For NIH.

February 9, 2007

NCAB To Hear Program Reviews, Try Again On Act Revisions

October 22, 1976

Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.

March 31, 2000

In Brief: Brady Wins ACRO Gold Medal; Society Elects New Fellows; Calabresi Honored

July 5, 1996